Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID 19
Carvallo Héctor, Hirsch Roberto, Farinella María Eugenia
doi: https://doi.org/10.1101/2020.09.10.20191619
Carvallo Héctor
1Professor of Internal Medicine, Universidad Abierta Interamericana, Argentina; Academic Coordinator at Eurnekian Public Hospital, Argentina
Hirsch Roberto
2Director of Postgraduate degree program in Infectious Diseases, Universidad de Buenos Aires, Argentina; Head of Department of Infectious Diseases at Hospital of Infectious Diseases Francisco Javier Muñiz, Buenos Aires, Argentina
Farinella María Eugenia
3Head of Service of Clinical Medicine at Eurnekian Public Hospital, Argentina
Data Availability
Data available on request.
Posted September 15, 2020.
Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID 19
Carvallo Héctor, Hirsch Roberto, Farinella María Eugenia
medRxiv 2020.09.10.20191619; doi: https://doi.org/10.1101/2020.09.10.20191619
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)